IBA sells part of dosimetry unit

By AuntMinnie.com staff writers

December 17, 2019 -- Proton therapy developer Ion Beam Applications (IBA) has sold its RadioMed unit to IZI Medical Products for an estimated price of $14 million to $16 million.

RadioMed, which IBA acquired in 2003, makes Visicoil, an implantable fiducial marker for soft-tissue tumor localization designed to enhance the accuracy of radiation therapy planning and delivery. IZI develops, manufactures, and provides medical consumable devices for interventional radiology and oncology, radiation therapy, neuro-spine, and image-guided surgery procedures.

IBA will retain ownership of the rest of its dosimetry products and business.


Copyright © 2019 AuntMinnie.com
 

To read this and get access to all of the exclusive content on AuntMinnie.com create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnie.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking
account: